Chemical Exposure

Chemical Exposure as a Personal Injury Claim

Chemical exposure cases are among the most complex and highest-value personal injury claims in New York. They are also among the most underreported — because the injuries they cause are often latent, appearing years or decades after the exposure occurred, many people never connect their diagnosis to the workplace, the water, or the environment that caused it.

The legal framework for chemical exposure cases in New York draws on several overlapping bodies of law. CPLR §214-c provides a modified statute of limitations for latent exposure cases, starting the clock from the date of discovery rather than the date of exposure — a critical provision given that diseases like mesothelioma can take 20 to 50 years to develop after asbestos exposure. Federal law adds another layer: the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), commonly known as Superfund, gives the EPA authority to compel cleanups and hold polluters accountable for contamination. State environmental law and products liability law provide additional pathways for recovery depending on the nature of the exposure.

What makes chemical exposure cases different from other personal injury cases is the role of corporate knowledge. In asbestos litigation, in PFAS litigation, and in benzene cases, internal documents have consistently shown that manufacturers knew about the health risks of their products decades before that knowledge was made public. That concealment — the deliberate suppression of scientific data about carcinogenic chemicals — is what drives the punitive damages awards that make chemical exposure verdicts some of the largest in American tort history.

If you believe a chemical exposure contributed to your illness, understanding what category of claim applies to your situation is the first step. The sections below cover each major category in depth.

Asbestos and Mesothelioma in New York

New York has one of the most active asbestos litigation dockets in the country. The New York City Asbestos Litigation (NYCAL) is a dedicated docket in Manhattan’s Supreme Court that has processed thousands of asbestos cases over several decades. New York’s industrial history — its shipyards, construction sites, power plants, schools, and manufacturing facilities — created some of the heaviest asbestos exposure in the country.

What Is Asbestos and Why Is It Dangerous

Asbestos is a naturally occurring mineral fiber that was used extensively in construction, insulation, shipbuilding, and manufacturing throughout most of the twentieth century. It was prized for its heat resistance, tensile strength, and low cost. Manufacturers, builders, and employers knew by at least the 1930s — and in some cases earlier — that inhaling asbestos fibers caused fatal lung disease. That knowledge was systematically suppressed for decades.

When asbestos-containing materials are disturbed — during construction, renovation, demolition, or maintenance — microscopic fibers are released into the air. These fibers, once inhaled, embed permanently in the lining of the lungs, abdomen, or heart. The body cannot break them down. Over years and decades they cause chronic inflammation that can develop into mesothelioma, asbestosis, or asbestos-related lung cancer.

Mesothelioma is the most aggressive asbestos-related disease — a cancer of the mesothelium, the thin membrane lining the lungs and abdomen. It is almost exclusively caused by asbestos exposure. The latency period — the time between first exposure and diagnosis — typically ranges from 20 to 50 years, which is why people are being diagnosed today from exposures that occurred in the 1960s, 70s, and 80s. In 2024, 1,907 mesothelioma lawsuits were filed in the United States, with cases filed in 2024 reflecting a 4% increase in asbestos-related lung cancer filings from the year prior.

Who Is at Risk

The populations most commonly affected by asbestos exposure in New York include construction workers — particularly those who worked with insulation, fireproofing, floor tiles, ceiling tiles, pipe wrap, and roofing materials from the 1940s through the 1980s. Ironworkers, pipefitters, electricians, plumbers, carpenters, and demolition workers all had significant exposure. Shipyard workers and Navy veterans were exposed through the extensive use of asbestos insulation in ship construction. Workers in power plants, refineries, and industrial facilities were exposed through boiler insulation and mechanical equipment. First responders and residents in Lower Manhattan who were present on or after September 11, 2001, were exposed to asbestos and other toxic materials released by the collapse of the World Trade Center — a category of claims that has its own dedicated compensation framework through the September 11th Victim Compensation Fund.

Secondary exposure — family members who washed the work clothes of an asbestos worker and inhaled fibers that came home on those clothes — is also recognized as a basis for mesothelioma claims in New York.

The 2024 EPA Asbestos Ban

In March 2024, the EPA finalized a ban on chrysotile asbestos — the only form of asbestos still commercially imported and used in the United States — under the Toxic Substances Control Act. Chrysotile was used primarily in the manufacture of chlorine and potassium hydroxide through diaphragm cells, and in certain gaskets and sheet gaskets. The ban takes effect in stages, with most uses prohibited within two years of the rule’s finalization. This marks the first comprehensive federal asbestos ban in American history, decades after the material was phased out in most consumer products.

Asbestos Trust Funds

Many of the companies that manufactured and sold asbestos-containing products have filed for bankruptcy under the weight of asbestos litigation. As part of those bankruptcy proceedings, they were required to establish dedicated asbestos trust funds to compensate current and future claimants. Over $30 billion is currently available across dozens of asbestos trust funds in the United States. Claiming from these trusts is a separate process from filing a lawsuit — an attorney with experience in asbestos litigation will identify which trusts a claimant may be eligible to recover from and file simultaneously, often resulting in compensation from multiple trusts in addition to any lawsuit recovery.

What Asbestos and Mesothelioma Cases Are Worth

Mesothelioma cases consistently produce some of the highest verdicts in New York personal injury litigation. The average mesothelioma settlement is between $1 million and $1.4 million. The average mesothelioma trial verdict is between $2.4 million and $11.4 million. Individual cases have produced far higher recoveries. A November 2024 trial resulted in a $22.5 million award to an 81-year-old military veteran and chemical engineer. In July 2024, a court awarded a former Avon employee $24.4 million after he developed mesothelioma from asbestos exposure at a Chicago-area factory. In April 2024, a family received $45 million in a wrongful death case against Johnson & Johnson after their family member developed mesothelioma from talc baby powder use.

New York verdicts from the NYCAL docket have included multiple nine-figure awards in cases involving occupational exposure. In cases where the defendant company knew about asbestos risks and concealed that knowledge, punitive damages are available in addition to compensatory damages — which is a significant driver of large verdicts in the most egregious cases.

The Statute of Limitations for Asbestos Claims in New York

CPLR §214-c governs the statute of limitations for latent exposure cases in New York, including asbestos. The three-year clock begins running from the date the injury was discovered or reasonably should have been discovered — in practice, this means from the date of mesothelioma diagnosis. New York’s statute of limitations for mesothelioma is three years from the date of diagnosis. Wrongful death claims brought by the family of someone who has died from mesothelioma have a separate deadline that runs from the date of death. Do not wait to consult an attorney after a diagnosis — the complexity of identifying all responsible parties and filing against the correct trusts and defendants takes time that the limitations period does not provide.

PFAS — Forever Chemicals

Per- and polyfluoroalkyl substances — PFAS — are a class of more than 12,000 synthetic chemicals that have been used in industrial and consumer products since the 1940s. They are found in nonstick cookware, waterproof clothing, food packaging, carpets, firefighting foam, and hundreds of other products. They are called forever chemicals because the carbon-fluorine bond that makes them useful — extremely stable, heat-resistant, and water-repellent — also makes them essentially indestructible in the environment and in the human body. PFAS do not break down. They accumulate in soil, groundwater, surface water, and human tissue over time.

The two PFAS compounds with the most extensive litigation history are perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). PFOA was used primarily in the manufacture of Teflon and other fluoropolymer products. PFOS was used primarily in firefighting foam — specifically the Aqueous Film-Forming Foam (AFFF) used at military bases, airports, and industrial fire training facilities — as well as in Scotchgard fabric protector. Both chemicals were manufactured and sold for decades by companies including 3M, DuPont, Chemours, and their predecessors, with full knowledge of their persistence in the environment and their association with cancer and other serious health conditions.

Health Effects of PFAS Exposure

The scientific evidence linking PFAS exposure to human disease has grown substantially over the past decade. In November 2023, the International Agency for Research on Cancer (IARC) classified PFOA as carcinogenic to humans (Group 1) — the highest classification — and PFOS as possibly carcinogenic (Group 2B). The EPA’s own toxicity assessments, supporting the 2024 National Primary Drinking Water Regulation, concluded that PFOA and PFOS are likely to be carcinogenic to humans.

The health conditions most strongly linked to PFAS exposure include kidney cancer, testicular cancer, bladder cancer, liver cancer, thyroid cancer, thyroid disease, and ulcerative colitis. These are the six conditions currently recognized in the AFFF MDL (MDL 2873) as qualifying for personal injury claims. Additional conditions under scientific investigation include prostate cancer, ovarian cancer, breast cancer, non-Hodgkin’s lymphoma, and developmental effects in children including low birth weight and immune system disruption. A 2025 study found that communities with PFAS-contaminated drinking water experienced up to 33% higher rates of certain cancers.

The PFAS Litigation Landscape

PFAS litigation is currently the largest and most active mass tort in the United States. It is proceeding on two parallel tracks: water system contamination cases, where municipalities and public water providers are suing PFAS manufacturers for the cost of detecting and removing these chemicals from drinking water; and personal injury cases, where individuals who developed cancer or other serious illness from PFAS exposure are suing for compensation.

The Water System Settlements

The water system track of PFAS litigation has already produced landmark settlements. In June 2023, 3M agreed to pay up to $12.5 billion over 13 years to settle claims from public water systems across the country that had been contaminated with PFAS from AFFF firefighting foam. The same month, DuPont, Chemours, and Corteva settled with drinking water providers for $1.18 billion. In November 2024, a federal judge approved two additional settlements: Tyco Fire Products agreed to pay $750 million and BASF Corporation agreed to pay $316.5 million to resolve PFAS contamination claims from public water systems.

In August 2025, New Jersey reached a $2 billion settlement with DuPont, Chemours, and Corteva for PFAS contamination at multiple sites across the state. In May 2025, 3M separately agreed to a settlement worth up to $450 million with New Jersey. These are state-level environmental settlements separate from the federal MDL.

The Personal Injury Track

The personal injury cases — brought by individuals who developed cancer from PFAS-contaminated water or AFFF exposure — are centralized in MDL 2873 in the United States District Court for the District of South Carolina before Judge Richard M. Gergel. As of early 2026, the MDL includes over 15,000 pending personal injury lawsuits — making it one of the largest MDLs in the nation. Unlike the water system settlements, the personal injury claims have not yet been resolved. No trial verdicts have been reached and no global personal injury settlement has been finalized as of the publication of this article.

The personal injury MDL has been moving toward bellwether trials — individual test cases chosen to represent the broader litigation and help both sides gauge how juries will value different types of PFAS injuries. Early bellwether cases were expected to focus on kidney cancer and testicular cancer claims. As of August 2025, the court had vacated the prior bellwether schedule under Case Management Orders 35 and 36 and established a filing facilitation window to organize claims, with renewed focus on driving the litigation toward resolution. Attorneys on both sides are engaging with a mediator in confidential settlement negotiations. Settlements for personal injury claims are expected to come once bellwether trial outcomes establish the value of different injury categories.

The EPA’s Regulatory Framework

The regulatory backdrop for PFAS litigation has shifted dramatically in recent years, substantially strengthening plaintiffs’ positions in personal injury and contamination cases.

In April 2024, the EPA issued the first-ever national legally enforceable drinking water standards for PFAS, setting maximum contaminant levels (MCLs) for PFOA, PFOS, and four other PFAS compounds. The rule is estimated to reduce PFAS exposure for approximately 100 million people and prevent thousands of deaths annually.

Also in April 2024, the EPA finalized a rule designating PFOA and PFOS as hazardous substances under CERCLA (Superfund), effective July 8, 2024. This designation requires entities to report releases of these chemicals exceeding one pound in any 24-hour period, and empowers the EPA to compel investigations and cleanups at contaminated sites using the full authority of Superfund law. Critically for litigation, the CERCLA designation means that those responsible for PFAS contamination can be held strictly liable for cleanup costs — the same liability framework that has driven billions in Superfund recoveries at other contaminated sites. As of September 2025, the EPA confirmed it will retain and defend the PFOA and PFOS hazardous substance designations under the current administration.

PFAS in New York

New York has been one of the most significant PFAS contamination sites in the country. The Hoosick Falls contamination — where PFAS from a manufacturing facility contaminated the municipal water supply of a small upstate New York community for years — became one of the first major PFAS cases to produce a substantial recovery. In July 2025, a $92 million-plus settlement was reached in the Hoosick Falls case, including $27 million from DuPont.

Long Island’s drinking water has been identified as having elevated PFAS contamination, linked to military base operations and industrial activity. PFAS contamination has been detected in water supplies serving communities near former Air Force bases, fire training facilities, and industrial sites across upstate New York. Residents of these communities who developed cancer or serious illness from contaminated drinking water may have claims in the federal MDL and potentially in state court under New York law.

Who Is Eligible to File a PFAS Claim

The populations most likely to have viable PFAS personal injury claims are those with documented exposure and a qualifying diagnosis. The conditions currently recognized in the MDL as qualifying include kidney cancer, testicular cancer, thyroid cancer, liver cancer, bladder cancer, and ulcerative colitis. If you have been diagnosed with any of these conditions and have a history of exposure to PFAS through any of the following sources, you should consult an attorney immediately:

Military service at or near a base where AFFF firefighting foam was used in training — this includes virtually every military airfield in the United States. Employment as a firefighter or airport fire safety worker with exposure to AFFF. Residence near a military base, airport, industrial facility, or waste disposal site with documented PFAS contamination. Regular consumption of water from a municipal system with known PFAS contamination. Occupational exposure through manufacturing processes involving PFAS chemicals.

Firefighters who wore turnout gear containing PFAS are pursuing a separate but related litigation track. Cases involving firefighter turnout gear remain part of MDL 2873, with claims focused on PFAS absorbed through the skin and lungs from protective equipment that was itself contaminated.

There is no clear settlement timeline yet for personal injury claims. The filing facilitation window established by the court created pathways for cases filed through September 2025 to receive better procedural treatment within the MDL. Anyone with a potential PFAS personal injury claim should consult an attorney now rather than waiting for settlement announcements — the procedural clock in MDLs matters, and late filings face stricter requirements.

Benzene and Petrochemical Exposure

Benzene is a naturally occurring component of crude oil and is also produced as a byproduct of industrial combustion processes. It is one of the most widely studied human carcinogens — the National Cancer Institute classifies benzene as a known human carcinogen with a well-established causal link to acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL), non-Hodgkin’s lymphoma, multiple myeloma, and aplastic anemia.

Benzene exposure claims arise most commonly from occupational settings: oil refinery workers, chemical plant workers, rubber industry workers, gas station attendants, shoe manufacturers, and workers in auto repair and body shops who handle benzene-containing solvents and degreasers. More recently, benzene has been identified in certain personal care products — including dry shampoos and sunscreens — at levels that exceed FDA guidelines, spawning a new generation of consumer product benzene litigation.

Benzene litigation follows a products liability framework. The manufacturer or distributor of a benzene-containing product that fails to adequately warn of its carcinogenic properties can be held liable for cancers that result from exposure. Cases typically require expert testimony establishing both the plaintiff’s level of exposure and the causal link between that exposure and the specific cancer diagnosed. New York courts have a significant benzene litigation docket, including occupational exposure cases with multi-million dollar verdicts.

Roundup and Glyphosate

Roundup, Monsanto’s widely-used herbicide, has been the subject of one of the largest mass tort litigations in recent history based on its primary ingredient, glyphosate. The International Agency for Research on Cancer classified glyphosate as a probable human carcinogen in 2015. Monsanto, now owned by Bayer, has paid over $10 billion in settlements to resolve Roundup cancer claims, predominantly from plaintiffs diagnosed with non-Hodgkin’s lymphoma after years of agricultural or occupational exposure. Litigation continues for claimants whose cases were not included in prior settlement rounds.

Lead Poisoning

Lead is a potent neurotoxin with no safe level of exposure, particularly for children. The CDC has established that there is no safe blood lead level in children — any detectable amount causes neurological harm. Lead exposure in New York most commonly occurs through lead paint in older housing stock, lead-contaminated soil near industrial facilities, lead service lines in municipal water infrastructure, and certain consumer products including imported toys and jewelry.

New York City has some of the oldest housing stock in the country, with an enormous proportion of pre-1978 buildings that contain lead paint. New York City’s Local Law 1 of 2004 imposes extensive lead paint disclosure and remediation obligations on landlords. Landlords who fail to comply and whose tenants’ children are diagnosed with elevated blood lead levels face significant personal injury liability — both in tort and under the statute — for the neurological, developmental, and cognitive harm caused by lead poisoning.

Lead poisoning cases involving children typically seek compensation for lifelong cognitive impairment, reduced educational attainment, increased risk of behavioral disorders, and diminished earning capacity. New York courts have awarded substantial verdicts in childhood lead poisoning cases, particularly where landlords had prior notice of lead hazards and failed to remediate them.

Pesticides and Agricultural Chemicals

Agricultural workers, landscapers, golf course maintenance workers, and others with occupational pesticide exposure face elevated risks of certain cancers, neurological disorders, and reproductive harm. The most significant current litigation involves organophosphate pesticides and their association with Parkinson’s disease and non-Hodgkin’s lymphoma, and chlorpyrifos — a widely-used insecticide — and its association with developmental neurotoxicity in children.

Chlorpyrifos was the subject of extended regulatory battles that ultimately resulted in EPA revocation of all food residue tolerances in 2021. Studies have linked prenatal exposure to chlorpyrifos with reduced IQ, attention deficit disorders, and other developmental harms in children. Cases arising from agricultural communities where chlorpyrifos was applied near schools and residential areas have been filed in multiple jurisdictions.

Paraquat, a highly toxic herbicide, has been linked to Parkinson’s disease in a growing body of scientific literature. Paraquat litigation has grown substantially over the past several years, with tens of thousands of plaintiffs alleging they developed Parkinson’s after occupational or residential exposure to this herbicide. The litigation is centralized in a federal MDL in the Southern District of Illinois.

Toxic Mold

Exposure to certain molds — particularly Stachybotrys chartarum, commonly called black mold — in indoor environments has been linked to respiratory illness, neurological symptoms, and immune system disruption. Toxic mold cases in New York arise most commonly in the context of premises liability: a landlord or building manager who knew or should have known about water intrusion and mold growth and failed to remediate it can be held liable for the health consequences to tenants or occupants.

New York landlords have obligations under the warranty of habitability under Real Property Law §235-b to maintain residential properties in a condition fit for human habitation — a standard that courts have interpreted to include remediation of toxic mold conditions. Tenants who develop respiratory disease, hypersensitivity pneumonitis, or other conditions attributable to prolonged mold exposure may have claims both under the warranty of habitability and in tort for the landlord’s negligence in allowing the condition to persist.

How to Prove a Chemical Exposure Case

Chemical exposure cases require three things that standard negligence cases do not always require in the same form: proof of exposure, proof of causation, and proof that the defendant knew or should have known about the risk.

Proving exposure means establishing that you were actually exposed to the substance, when the exposure occurred, and at what level or dose. In occupational exposure cases this typically involves employment records, industrial hygiene data, and testimony from coworkers. In contaminated water cases it involves water testing data, records of your residence in a contaminated service area, and your period of residence. Expert industrial hygienists and exposure scientists are critical to quantifying the dose, which is often the determinative question in causation.

Proving causation in chemical exposure cases requires medical expert testimony establishing that the specific substance to which you were exposed, at the level of that exposure, is capable of causing the disease you developed — and that it did so in your particular case. This is called general causation (does the substance cause this disease?) and specific causation (did the substance cause this disease in this person?). Both must be established. Defense lawyers aggressively challenge expert causation testimony through Daubert motions — motions to exclude expert witnesses whose methodology doesn’t meet federal or state evidentiary standards. Winning those challenges is one of the central battlegrounds in chemical exposure litigation.

The corporate knowledge element distinguishes many chemical exposure cases from ordinary negligence. Where plaintiffs can show through internal documents — obtained during discovery or through prior litigation — that the defendant knew about the health risks of a substance and failed to warn or continued to market it despite that knowledge, punitive damages become available. It is this element that has driven the billion-dollar verdicts in asbestos, tobacco, and Roundup litigation.

Statute of Limitations for Chemical Exposure Claims in New York

CPLR §214-c is the governing statute of limitations for chemical exposure cases in New York. It provides a three-year window that runs from the date of discovery — defined as the date the plaintiff knew or should have known that they had been injured and that the injury was caused by the exposure. This discovery rule is essential for latent exposure claims because the disease may not manifest until decades after the exposure occurred.

The practical application of the discovery rule varies by case type. In mesothelioma cases, the clock typically starts from the date of diagnosis — because mesothelioma is virtually always caused by asbestos, a diagnosed patient should at that point know or be able to determine that an asbestos exposure caused their disease. In PFAS cases, the question of when a person “should have known” their cancer was caused by water contamination is more fact-specific and is an active area of litigation.

For wrongful death claims — brought by the family of someone who died from a chemical exposure-related disease — New York Estates, Powers and Trusts Law §5-4.1 provides a two-year statute of limitations running from the date of death.

Municipal defendants — including public housing authorities, city agencies, or public water systems — require a Notice of Claim within 90 days of the date the injury is discovered, before a lawsuit can be filed. If a government entity contributed to the chemical exposure, the procedural clock is dramatically shorter.

The calculation of which statute of limitations applies, when it began to run, and whether any tolling applies is often the most contested threshold question in chemical exposure litigation. Do not assume your claim is time-barred without consulting an attorney — courts have recognized several tolling doctrines that can extend these deadlines, and the applicable state may not be obvious when exposure occurred across multiple jurisdictions or states.

What to Do If You Were Exposed to a Toxic Chemical

The most important thing you can do after any chemical exposure diagnosis is to act quickly. Every passing day increases the risk that evidence — employment records, water testing data, industrial records, company documents — becomes harder to locate or is destroyed. Document your exposure history in as much detail as possible while your memory is fresh: where you worked, what products you used, what your workplace conditions were, where you lived, and what your water source was. Write it down.

See your physician immediately and make sure your diagnosis and your exposure history are fully documented in your medical records. Ask your doctor to note your occupational and residential exposure history explicitly in the chart — this creates a contemporaneous record connecting your illness to your exposure, which is invaluable in litigation.

Preserve any physical evidence. Do not throw away any product that you believe may have contributed to your exposure. Preserve work records, pay stubs, union cards, tax records, and any other documentation of your employment history. If you have water bills or utility records from a residence in a PFAS-contaminated area, preserve those too.

Consult an attorney who specifically handles toxic tort or chemical exposure cases — not a general personal injury attorney. Chemical exposure litigation involves specialized expert networks, complex causation science, and knowledge of specific MDLs, trust fund systems, and regulatory frameworks that require dedicated expertise. Ask the right questions when choosing your attorney — specifically about their experience with the type of exposure involved in your case and what MDLs or trust fund systems they work within.

Most toxic tort attorneys work on contingency — you pay nothing unless they win. Given the resources required to litigate chemical exposure cases — expert witnesses alone can cost hundreds of thousands of dollars — the contingency fee arrangement is standard and essential in this area of law. Know your filing deadline and do not miss it. In chemical exposure cases, the statute of limitations is often the single most critical threshold issue — cases that are dismissed as time-barred cannot be refiled.

If you believe you have a chemical exposure claim, use our free case evaluation tool to connect with an attorney at no cost to you.